LOTUSEYE.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 09:22):

Stats
Tagesvolumen	13 937.00
Durchschnittsvolumen	319 699
Marktkapitalisierung	1.27B
EPS	INR0 ( 2024-02-15 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-21
Last Dividend	INR0.500 ( 2023-09-18 )
Next Dividend	INR0 ( N/A )
P/E	35.88
ATR14	INR0.406 (0.66%)

Volumen Korrelation

Lang: 0.17 (neutral)

Kurz: 0.62 (weak)

Signal:(53.592) Neutral

Lotus Eye Hospital and Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Lotus Eye Hospital and Korrelation - Währung/Rohstoff

-0.06
( neutral )

-0.03
( neutral )

0.00
( neutral )

-0.05
( neutral )

0.32
( neutral )

0.08
( neutral )

Lotus Eye Hospital and Finanzdaten

Annual	2022
Umsatz:	INR470.44M
Bruttogewinn:	INR250.59M (53.27 %)
EPS:	INR1.960

FY	2022
Umsatz:	INR470.44M
Bruttogewinn:	INR250.59M (53.27 %)
EPS:	INR1.960

FY	2022
Umsatz:	INR380.86M
Bruttogewinn:	INR192.62M (50.58 %)
EPS:	INR1.440

FY	2021
Umsatz:	INR316.67M
Bruttogewinn:	INR160.14M (50.57 %)
EPS:	INR0.751

Financial Reports:

No articles found.

Lotus Eye Hospital and Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Lotus Eye Hospital and Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.78 - low (50.00%) | Divividend Growth Potential Score: 4.37 - Stable (12.63%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2017-08-02
Last Dividend	INR0.500	2023-09-18
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR2.50	--
Avg. Dividend % Per Year	0.55%	--
Score	1.54	--
Div. Sustainability Score	2.78
Div.Growth Potential Score	4.37
Div. Directional Score	3.57	--

Next Divdend (Est)
(2025-02-04)

INR0.506 Estimate 2.90 %

Dividend Stability

0.23 Very Poor

Dividend Score

1.54

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	INR0	0.00%
2018	INR0.500	1.72%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0.500	1.45%
2022	INR0.500	0.95%
2023	INR0.500	0.62%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SARDAEN.NS	Dividend Junior	2023-09-07	Annually	15	0.65%
MAGADSUGAR.NS	Dividend Junior	2023-07-13	Annually	7	1.78%
GMDCLTD.NS	Dividend Knight	2023-09-22	Annually	23	3.41%
ASTRAMICRO.NS	Dividend Junior	2023-08-23	Annually	20	0.49%
TITAN.NS	Dividend Junior	2023-07-13	Annually	20	0.35%
PETRONET.NS	Dividend Knight	2023-08-18	Semi-Annually	18	2.36%
JASH.NS	Dividend Junior	2023-09-22	Annually	7	0.57%
DBOL.NS	Dividend Junior	2023-06-23	Insufficient data to determine frequency	2	0.56%
SILINV.NS	Dividend Junior	2023-08-18	Annually	23	0.63%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0730	1.500	8.54	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0608	1.500	-0.435	-0.653	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	51.85	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.26	2.00	8.91	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.26	2.00	8.37	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.451	1.000	5.81	5.81	[0.2 - 0.8]
operatingProfitMarginTTM	0.0909	1.000	-0.182	-0.182	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.78

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	35.59	1.000	6.51	0	[1 - 100]
returnOnEquityTTM	0.0608	2.50	-0.280	-0.653	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.26	2.00	8.91	10.00	[0 - 30]
dividendYielPercentageTTM	0.826	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.26	2.00	8.91	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.387	1.500	-0.754	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.140	1.000	9.01	0	[0.1 - 0.5]
Total Score				4.37

Lotus Eye Hospital and

Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.